Product Description
The Infant Phototherapy Unit YR06221 is a state-of-the-art device designed to provide effective treatment for neonatal jaundice. This highly efficient unit is equipped with advanced features that ensure optimal phototherapy performance. It delivers a bilirubin radiancy of 3750μw/cm² at a distance of 40cm and 3200μw/cm² at 50cm, ensuring adequate light exposure to the infant’s skin for therapeutic purposes.
This unit offers adjustable lighting intensity options of 33%, 67%, or 100%, allowing clinicians to tailor the treatment based on the needs of the infant. The inclusion of white light adds versatility, incorporating real-time visual assessments without interrupting therapy. Operating at a power of ≤60VA, it provides an energy-efficient solution for continuous care.
The YR06221 operates within a wavelength range of 400nm to 550nm and features a generous radiant space of 400×250mm. Its superior radiant uniformity, greater than 0.4, ensures that the light is evenly distributed over the treatment area. The device allows for precise therapy time settings ranging from 0 to 99 hours and 59 minutes, accommodating various treatment regimens.
| Model | YR06221 |
| Bilirubin Radiancy (40cm) | 3750μw/cm² (62.5μw/cm²/nm) |
| Bilirubin Radiancy (50cm) | 3200μw/cm² (53mw/cm²/nm) |
| Lighting Intensity | 33%, 67%, 100% |
| White Light | Yes |
| Power | ≤60VA |
| Wave Length | 400nm~550nm |
| Radiant Space | 400×250mm |
| Radiant Uniformity | >0.4 |
| Therapy Time Set | 0-99h59m |
| Height Range | 1350mm~1650mm |
Market Price
The Infant Phototherapy Unit YR06221 is positioned as a competitively priced product within the market, offering great value for healthcare facilities looking for efficient and reliable neonatal care equipment. The market price for this unit typically ranges from $1500 to $2200, depending on features, region, and supplier specifics. This pricing reflects the advanced technology and robust build of the unit, making it a prudent choice for hospitals and clinics seeking dependable neonatal care solutions.
Frequently Asked Questions
How does the YR06221 unit work?
The YR06221 phototherapy unit operates by emitting light in the blue spectrum, which helps break down bilirubin in the infant’s skin, reducing jaundice levels efficiently. It provides adjustable intensity settings to customize treatment based on the infant’s conditions.
What makes this phototherapy unit unique?
This unit stands out due to its excellent irradiance levels, adjustable light intensity, and the inclusion of white light, which facilitates continuous infant monitoring without interrupting therapy.
Is the device energy-efficient?
Yes, the unit operates with a power consumption of ≤60VA, making it an energy-efficient choice for continuous use in neonatal care settings.
Advantages and Disadvantages
Advantages: The main advantages of the YR06221 phototherapy unit include its high bilirubin radiancy and customizable intensity settings. This facilitates effective treatment and adaptability to different patient needs. Additionally, the use of white light allows continuous monitoring of the infant.
Disadvantages: While the unit offers numerous benefits, it may require careful setup and ongoing training for best results. The device’s price range, although competitive, may also be a consideration for smaller facilities with limited budgets.
Use of the Product in the Field
In practical scenarios, the YR06221 is utilized in neonatal wards and pediatric care units. It is employed to treat infants with jaundice by hospital staff trained to set the appropriate wavelength and intensity levels. Its efficient design allows for easy adjustment and operation within diverse clinical settings.
The adjustable height range of 1350mm to 1650mm offers flexibility in different environments, making it a versatile choice for varied ward configurations. Its radiant uniformity ensures comprehensive coverage, critical for effective phototherapy treatment.
Recommendations
To maximize the efficiency of the YR06221 in clinical use, it is recommended to regularly calibrate the device to maintain optimal light intensity. Routine maintenance and checks are advised to ensure device longevity and consistent performance in treating neonatal jaundice.
Training staff on the device’s features and settings can further enhance therapeutic outcomes, ensuring that the infants receive the full benefits of the phototherapy unit. Consider leveraging the Kalstein Plus platform to conveniently explore financing options and procure the YR06221 unit for your institution.
If you are seeking a fusion of innovation and quality, you have come to the right place. At Kalstein, we offer you the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture each piece of equipment with a level of excellence. Our intuitive and agile online purchasing channels are designed for your convenience, ensuring the most friendly prices. Don’t hesitate any longer, we bring science to life; it is time to become part of our community. https://kalstein.net/en/product/infant-phototherapy-unit-yr06221/.
